Biotas One Injection

Introduction

Biotas One is a prescription medication that contains Sodium Hyaluronate as its active ingredient. It is commonly known by its generic name and is used to provide relief for certain joint conditions.

Uses

Biotas One is primarily prescribed to treat osteoarthritis of the knee. It helps to alleviate pain and improve joint function in individuals with this condition. Osteoarthritis is a common degenerative joint disease that causes the cartilage in the joints to break down over time, leading to pain, stiffness, and reduced mobility.

Dosage and Administration

Biotas One is administered by a healthcare professional directly into the affected joint. The dosage and frequency of injections will depend on the severity of the osteoarthritis and the individual patient’s response to treatment. Follow the instructions provided by your healthcare provider and not to self-administer this medication.

Mechanism of Action

Sodium Hyaluronate, the active ingredient in Biotas One, is a naturally occurring substance found in the body’s joint fluid. It acts as a lubricant and shock absorber, helping to reduce friction and cushion the joints. By injecting Sodium Hyaluronate directly into the affected joint, Biotas One helps to restore the natural balance of joint fluid and improve joint function.

Side Effects

Common side effects of Biotas One may include mild pain or swelling at the injection site, temporary worsening of joint pain, and mild allergic reactions such as redness or itching. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, contact your healthcare provider.

Drug Interactions

Biotas One is generally well-tolerated and has a low risk of drug interactions. However, it is always important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, supplements, and herbal remedies, as they may interact with Sodium Hyaluronate.

Precautions

Before using Biotas One, inform your healthcare provider if you have any known allergies to Sodium Hyaluronate or any other ingredients in the medication. Additionally, if you have an active infection or skin disease in the area where the injection will be given, it is advisable to delay the treatment until the infection or skin disease has resolved.

Storage

Biotas One should be stored at room temperature, away from direct sunlight and heat sources. Keep it out of the reach of children and pets. Do not freeze the medication. If you have any expired or unused medication, please consult with your healthcare provider or pharmacist on proper disposal methods.

Patient Tips

• Follow the recommended treatment schedule provided by your healthcare provider.
• Avoid excessive physical activity or putting undue stress on the treated joint immediately after the injection.
• If you experience any new or worsening symptoms after the injection, such as increased pain, swelling, or redness, contact your healthcare provider.
• maintain a healthy lifestyle, including regular exercise and a balanced diet, to support overall joint health.
• If you have any concerns or questions about your treatment with Biotas One, do not hesitate to reach out to your healthcare provider for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Vitamins and minerals – Others (NHS UK) [Accessed 11 Jun. 2024] (online) Available at:
• Sodium hyaluronate injection (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
• sodium hyaluronate 10 mg/ml intra-articular solution (RX) [Accessed 26 Jun. 2024] (online) Available at:
• Medicines, injections, and supplements for arthritis (MedlinePlus) [Accessed 9 Jun. 2024] (online) Available at:
• Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW; Cosmetic Ingredient Review Expert Panel; Andersen FA. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol. 2009 Jul-Aug;28(4 Suppl):5-67. doi: 10.1177/1091581809337738. [Accessed 28 Jun. 2024] Available at: